site stats

Biochemics sec

WebMar 25, 2015 · The judgment entered on March 25, 2015, supplements the March 18, 2015 judgment, and requires BioChemics to disgorge $15,105,325 in ill-gotten gains plus … WebDec 16, 2012 · The SEC claims that in 2010 and 2011 BioChemics, Masiz, and Kroning misrepresented to investors and potential investors the status of research collaborations with other pharmaceutical companies: “For example, in 2010 and 2011, BioChemics published a multiple-page overview entitled Executive Summary (“Executive Summary”) that touted …

SEC Claims Three Recidivists Took Investors For Millions of …

WebJan 6, 2015 · Plaintiffs BioChemics, Inc., and John Masiz sued defendant Axis Reinsurance Company (“AXIS”) for defense costs arising out of a Securities and Exchange Commission (“SEC”) investigation and enforcement action under their directors and officers (“D & O”) liability insurance policy. WebThe relevant facts trace back to the SEC indictment of BioChemics and BioChemics’s CEO John Masiz for securities fraud in 2012. See SEC v. Biochemics, Inc., 435 F. Supp. 3d 281, 285 (D. Mass. 2024) (appeal dismissed as moot at SEC v. Masiz, No. 19-2206, No. 20-1177, No. 20- diabetic foot doctor harrison arkansas https://cortediartu.com

Ex-BioChemics CEO Tries To Slip

WebMay 23, 2024 · Plaintiffs sought damages for what they claimed was AXIS's breach, under the relevant policy, of its duty to defend them in connection with an investigation conducted by the Securities and Exchange Commission against BioChemics and its officers. WebJun 24, 2024 · In BioChemics, Inc. v. AXIS Reinsurance Co., 2024 WL 2223125 (1st Cir. May 23, 2024), the United States Court of Appeals for the First Circuit held that a D&O policy did not provide coverage for an SEC … WebMar 4, 2024 · biochemistry, study of the chemical substances and processes that occur in plants, animals, and microorganisms and of the changes they undergo during … cindy sherman untitled #96 1981

Biochemistry - Wikipedia

Category:The SEC Says BioChemics, Inc. Misrepresented its Collaborations with ...

Tags:Biochemics sec

Biochemics sec

1st Circ. Questions BioChemics Strategy In SEC Probe Case

WebDefine biochemics. biochemics synonyms, biochemics pronunciation, biochemics translation, English dictionary definition of biochemics. ... The SEC previously obtained a $17 million judgment against BioChemics and a separate judgment against a promoter of BioChemics stock who wasn't registered as a broker. WebDec 14, 2012 · BioChemics of Danvers faces fraud charges By Beth Healy Globe Staff,December 14, 2012, 2:17 p.m. Federal securities regulators on Friday filed civil fraud charges against BioChemics Inc. of...

Biochemics sec

Did you know?

WebThe SEC claimed in a 2012 lawsuit that BioChemics and Masiz lied about the status of topical gels that would allow medicine to be absorbed through the skin. They allegedly falsely asserted the... WebDec 16, 2012 · Three repeat securities law violators teamed up to defraud 70 investors of over $9 million over three years. The complaint claims the defendants sold interests in a privately held biochemical company based on a series of misrepresentations. SEC v. Biochemics, Inc., Civil Action No. 1:12-cv-12324 (D. Mass. Filed Dec. 14, 2012).

WebCompany profile page for BioChemics Inc including stock price, company news, press releases, executives, board members, and contact information Webthe SEC served document subpoenas on Biochemics and Masiz in March 2012 (during the policy period); and the SEC filed an enforcement action against Biochemics, Masiz, and two promoters retained by the company in December 2012 (after the expiration of the policy period). Biochemics notified AXIS of the January and March 2012 subpoenas.

WebAug 29, 2024 · According to the complaint, when BioChemics finally did conduct one clinical trial, it misrepresented the results of that trial. The complaint further alleged that Masiz … WebLaw360, Boston (October 10, 2024, 5:10 PM EDT) -- After dodging a $17 million payment to the U.S. Securities and Exchange Commission, BioChemics Inc. will have to deal with a court-appointed...

Webbiochemistry: [noun] chemistry that deals with the chemical compounds and processes occurring in organisms.

WebBiochemists work in industries like agriculture, medical research, biotechnology and nutritional research. Our students go on to positions in research and industry, as well as graduate study in biochemistry, … cindy sherman untitled film still #6WebDec 17, 2012 · Courthouse News Staff / December 17, 2012. BOSTON (CN) - An attorney duped investors for $9 million through his purported biopharma company, Biochemics, … cindy sherman untitled film still #56WebAug 22, 2024 · According to the SEC complaint, BioChemics, Masiz and co-conspirators were accused of engaging in a fraudulent scheme to sell company securities to approximately 70 investors. The scheme, which ran from 2009 until the middle of 2012, netted at least $9 million. Investors caught up in the scheme resided in 19 different states. cindy sherman untitled film still #48WebAug 7, 2013 · BioChemics is a specialty pharmaceutical company focused on transdermal drug delivery systems, including medicated lotions. Masiz is BioChemics's president and chief executive officer. In May 2011 and September 2011, the SEC served document subpoenas on BioChemics requesting a broad range of documents regarding the … cindy sherman untitled marilynWebLaw360, Boston (September 11, 2024, 6:30 PM EDT) -- The U.S. Securities and Exchange Commission and a Massachusetts federal judge appeared skeptical Tuesday of BioChemics Inc.'s claims that it... diabetic foot doppler studiesWebSep 6, 2024 · In Biochemics, Inc. v. AXIS Reinsurance Company, 2024 WL 2223125 (1st Cir. 2024), the SEC issued a subpoena to Biochemics on May 5, 2011, requesting that Biochemics produce certain documentation in connection with the SEC’s investigation into whether Biochemics and its President and CEO, John Masiz, had committed securities … cindy sherman untitled marilyn monroe 1982WebJan 14, 2014 · Biochemics, Inc. Overview. Biochemics, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on Tuesday, January 14, 2014 and is approximately nine years old, as recorded in documents filed with Texas Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state … diabetic foot dressing